Cardeza Foundation For Hemotological Research entered the industry of Medical Research in 1966 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Paul Bray by calling (215) 955-7786 during business hours. You can also write to the business’ Single Location at 1015 Walnut St 82, Philadelphia, Pennsylvania PA 19107. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Cardeza Foundation For Hemotological Research |
| Representative: | Paul Bray |
| Place of Business: | 1015 Walnut St 82, Philadelphia, PA 19107 |
| Contact Number: | (215) 955-7786 |
| Type of Service: | Medical Research |
| SIC Number: | 8733 |
| NAICS Number: | 541720 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 1966 |
| Income/Year: | $1.000.000 to $2.499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Cardeza Foundation For Hemotological Research is a company operating from Philadelphia, Pennsylvania providing professional Medical Research and relevant B2B variables. It was founded in 1966 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.
With a current employee count of 1 to 4, Cardeza Foundation For Hemotological Research has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Paul Bray at (215) 955-7786 for related queries, or to locate its Single Location using the coordinates 39.948745,-75.158381.
The Single Location can also be found at the street address 1015 Walnut St 82 in Philadelphia, Pennsylvania 19107 and can be engaged online through the company website at , the company Twitter , and Facebook page .